Wells Fargo & Company Organovo Holdings, Inc. Put Options Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ONVO
# of Institutions
35Shares Held
885KCall Options Held
16.2KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA354KShares$208,6310.0% of portfolio
-
Black Rock Inc. New York, NY142KShares$83,9020.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny97.8KShares$57,6940.0% of portfolio
-
Geode Capital Management, LLC Boston, MA74.9KShares$44,1960.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il46.4KShares$27,3610.0% of portfolio
About ORGANOVO HOLDINGS, INC.
- Ticker ONVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,712,020
- Market Cap $5.14M
- Description
- Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...